The biopsy devices market, valued at USD 2.3 billion in 2022, is poised for significant expansion, projected to reach USD 4.2 billion by 2032 at a robust CAGR of 6.1% from 2023 to 2032. This market ...

Learn about the key tests and methods used to diagnose stomach cancer, including endoscopy, biopsy, imaging studies, and more ...

As of 2022, the ultrasound-guided biopsy market was valued at USD 720 million, showing a consistent upward trend in response to the growing global need for early breast cancer detection. This momentum ...